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STRAKT
The authors conducted review of the scientific literature on the prevalence of mental disorders in the world and in Kharkiv region. There were studied some examples of forensic pharmacy practice re­
garding improper distribution of medicines, including extemporaneous formulations, to patients suf­
fering from mental health disorders. Based on the research, the authors discuss the problems of provid­
ing the eligible for aid patients suffering from mental disorders with extemporaneous medicines, and 
suggest making appropriate amendments to the normative documents. The authors draw a conclusion 
that the pharmaceutical law principles contribute to solving the problem of providing patients with 
mental health disorders with extemporaneous medicines by using the extemporaneous preparations 
made in pharmacies.
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НОТАЦИЯ
А вторами статьи проведен обзор научной литературы относительно распространенности пси­хических расстройств в странах мира и в Харьковском регионе. Изучены примеры из судеб­
но-фармацевтической практики относительно ненадлежащего обеспечения лекарственными 
средствами, в частности экстемпоральной рецептурой, больных с психическими расстройства­
ми здоровья. На основе проведенного исследования проработаны проблемные вопросы обеспе­
чения больных с психическими расстройствами, которые являются льготным контингентом, 
экстемпоральными лекарственными средствами, для чего предложено внесение соответствую­
щих изменений в нормативные документы. Установлено, что именно принципы фармацевтиче­
ского права способствуют решению проблемы обеспечения экстемпоральными лекарственны­
ми средствами больных с психическими расстройствами здоровья путем применения врачами 
экстемпоральных лекарственных средств, изготовленных в условиях аптеки.
Кл ю ч е в ы е  сл ова: фармацевтическое право; психические расстройства; больные; экстемпоральные лекарственные средства.
Васина Ю.В., 
Шаповалов В.В., 
Шаповалова ВА ., 
Ковалёва К.И.
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IN T R O D U C T IO N . Due to the high infor­
mational, psychological and emotional load on 
society there is an increased incidence of mental 
illness that require improvement of the efficien­
cy of healthcare and improved legal relationships 
in the “doctor -  patient -  pharmacist” system [4, 
8, 9, 14, 18, 20].
There are also the growth and scaling up of 
the industrial accidents in the world, including 
Japan, Ukraine, the European Union (EU), nat­
ural and everyday disasters that have serious 
medical and social, medical, pharmaceutical, 
criminal and penal consequences [2, 5, 11].
Aiming at the prevention of major accidents 
involving dangerous substances and in order to 
limit their social and environmental impacts that 
cause mental health problems over the popula­
tion, the EU adopted Directive 96/82/EU, which 
requires technicians to apply it to objects where 
the number of dangerous substances exceed cer­
tain thresholds [6]. In addition, the integration of 
Ukraine into the EU requires harmonization of 
national legislation and legal acts to EU directives 
that establish standards of medical and pharma­
ceutical provision for the population [21, 22, 26].
M a te ria ls  a n d  m e th o d s  o f  th e  re s e a rc h . 
The materials of the study included the EU Di­
rectives, legislation and regulations of Ukraine; 
the complaints received on the telephone hotline 
of the Department of Healthcare of Kharkiv Re­
gional State Administration; the examples from 
the forensic and pharmaceutical practice; the 
sources of scientific literature; the Internet sites; 
the processed extemporal medicines stocks is­
sued by doctors in public healthcare facilities. 
To achieve this goal, there were used generally 
accepted methods including legal, documentary 
analysis, forensic and pharmaceutical monitor­
ing, graphical and tabular methods of analysis.
R e su lts  o f  th e  r e s e a r c h . According to the 
official WHO statistics, mental illness affects 
about 450 million people, the most workable of 
the population, of which 10% are elderly people 
[17]. According to the research conducted by the 
government enterprise “The Institute of Neurol­
ogy, Psychiatry and Addiction” led by academic 
Voloshin P.V., every third person in the world 
suffers from various mental health disorders ac­
cording to ICD-10, whose share in the economi­
cally and industrially developed EU countries is 
82.8% in Eastern European countries (including
Ukraine) -  88.4%, in the Russian Federation -  
86.7%, in developing countries -  65.3%.
The prevalence of mental disorders in the EU 
is 15.0% of the total population; United States 
-  38%; Australia -  14.8% [15, 16]. According to 
forecast by the WHO, in 2020 in European coun­
tries mental health disorders will double [12, 13].
WHO data show that at the beginning of 2013:
-  450 million of the citizens around the world 
suffer from varying degrees of mental illness;
-  At least one person suffers from mental dis­
order from each 4th family in the world;
-  People that suffer from mental illness end 
their lives by suicides in 15-20%;
-  1% of the population suffers from schizo­
phrenia;
-  Mental disorders are found in 5% of chil­
dren in developing countries and in 0.5% of chil­
dren in developed countries;
-  In Europe, each family with four teens has 
mental illness or abnormalities in mental health.
The review of the scientific literature revealed 
that mental disorders -  disorders of mental ac­
tivity were established in accordance with the 
current in Ukraine ICD-10, injuries and causes of 
death. Mental health problems are common to all 
countries because more than 25% of the world’s 
population at some point in their lives suffer from 
one or more mental disorder. In 1998, the WHO 
initiated the “Mental health in the world 2000”, 
which was proposed in 28 countries of the world 
with epidemiological studies of mental health [17, 
27, 28]. Other countries are those where similar 
research was never carried out, including Ukraine. 
Describing the social consequences of mental dis­
orders, we need to note a reduced life expectancy 
of people with mental disorders (when compared 
with those who do not have them), social exclu­
sion and suicidal behavior that accompany this 
pathology, a significant deterioration in the qual­
ity of life of patients and their relatives. Accord­
ing to the WHO, mental disorders are the third 
of disabling conditions that lead to reduced life 
expectancy by an average of 10 years [20]. Effec­
tive cooperation in the primary care levels is an 
essential condition for effective implementation 
of the measures of psychosocial rehabilitation as 
an ultimate goal of re-socialization of patients’ re­
covery or formation of social autonomy, indepen­
dent functioning in society, expansion of social 
networks [1, 7].
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Fig. 1. The incidence o f  mental disorders in the world 
Рис. 1. Распространенность психических расстройств в мире
As shown in Fig. 1, the prevalence of men­
tal health problems is from 14.8% to 32.7% in 
gross morbidity in the world. Studies show that 
Ukraine is one of the European countries where 
there were serious problems in the prevention of 
the causes and conditions that lead to the devel­
opment of mental disorders -  almost 2 million 
of Ukrainians annually become psychiatric pa­
tients [15, 16]. It was found that in Ukraine, the 
prevalence of mental disorders is 10 times less 
than in Western Europe (24% of the population 
suffers from mental disorders). It is anticipated 
that by 2020, mental illness will enter the glob­
al top five disease-leaders and their share of all 
diseases could reach 50%. Therefore, the efforts 
of researchers around the world aimed at pre­
vention of mental illness. The world’s leading 
scientists Sahakyan Barbara and Thomas Insel 
encourage the new approaches in the develop­
ment of drugs to treat mental illness. They em­
phasize the acute shortage of new treatments for 
mental disorders, including Alzheimer’s disease, 
depression, neurosis and schizophrenia [12]. In 
turn, I. Pinchuk said that reforming the system 
of mental healthcare in healthcare professionals 
of the Ministry of Healthcare of Ukraine requires 
the following measures to [14]:
-  To ensure the institutional and legal 
framework to provide modern mental healthcare 
in health facilities;
-  To eliminate the effects of abuse by the 
psychoactive substances when providing mental 
healthcare;
-  Restoration of the rights of people, citizens 
and patients by granting them psychiatric and 
pharmaceutical care in mental health care 
facilities;
-  Solving the availability of the medicines 
to the privileged contingent of patients with 
preferential discounted prescriptions and 
improve relationships in the chain “doctor -  
patient -  pharmacist” in providing an individual 
approach to the manufacturing of the extemporal 
medicines.
The modern problems of psychogenic 
disorders caused by subjectively significant 
adverse events, according to N.A. Maruta, 
are relevant to the clinical practice and the 
development of the theory of the medical 
and pharmaceutical law, which requires a 
further study of the impact factors of modern 
psychological trauma in clinical and psychopathic 
structure of the dissociative disorders on the 
principles of medical law [9].
СЕРИЯ Медицина и фармация
22 Vasina J.V., ShapovalovV.V., Shapovalova V A ., Kovalyova K.I. Щ Щ А  У  Ч  Н  Ы  Й
Р Е З У Л Ь Т А Т
Сетевой научно-практический журнал
THE PRINCIPLES OF THE PHARMACEUTICAL LAW IN SOLVING PROBLEMS OF SUPPLYING 
PATIENTS WITH MENTAL HEALTH PROBLEMS WITH EXTEMPORAL MEDICINES
The next line of research is aimed at the study ing that there is a trend following prevalence of
of the prevalence of mental disorders in Kharkiv mental disorders at the regional level [15, 16, 17]
Region. To do this, the authors processed sta- (Table. 1).
tistical data for the period of 2012-2013, show-
Table 1
The incidence o f  mental disorders in Kharkiv Region 
in 2012-2013 (thousand people)
Таблица 1
Показатели распространенности психических расстройств 
в Харьковской области за 2012-2013 гг. (тыс. чел.)
In d ic a to r
Y e a r D y n a m ics,
%2012 2013
The prevalence of mental 
disorders among adults
116209 115195 -  0,87 %
The prevalence of mental 
disorders among children 14939 14393 -3,65 %
Number of patients who are 
under medical supervision 116775 115433 -1,15 %
As shown in Table 1, in 2013, there is a 0.87% 
decrease in the prevalence of mental health dis­
orders among adults which compared to the 
prevalence of mental disorders among children 
in 2012 has decreased by 3.65% (compared to 
2012). The number of patients under medical 
observation in 2013 also came to a decrease (by 
1.15% compared to 2012).
One of the measures to improve the ac­
cess of patients to personalized drug therapy 
is making extemporal medicines in conditions 
of pharmacies with the aim of providing an 
individual approach to the individual patient 
suffering from mental health disorders. Unfor­
tunately, the recent implementation of a hard 
market mechanism in the activities of pharma­
cies of communal ownership has led to what 
is not considered as forensic and pharmaceu­
tical risks. This is the reason for the fact that 
in Kharkiv Region on 10/01/2014 only 11 of 
municipal pharmacies are licensed to manu­
facture extemporal medicines [3], although in
70-80 years of the XX century, in the city of 
Kharkiv and Kharkiv Region there were 450 
such pharmacies. The level of cooperation of 
relations in the chain “doctor-patient-phar- 
m acist” reacts the pharmacy realities, because
every Sunday pharmacy representatives par­
ticipated in the “Days of the chief doctor” who 
performed municipal healthcare institutions. 
As part of the event pharmacy specialists in­
form doctors about the possibility of making 
the extemporal medicines in the pharmacies.
It was found that more and more practi­
tioners in pharmacies raise the question of 
decreasing the production of extemporal m ed­
icines in Ukraine, which is the result of diver­
sification of finished drugs. Thus, in our opin­
ion and the opinion of the leading scientists of 
Ukraine, namely Tikhonov O.I. Yarnyh T.G., 
Tolochko V.M., Ponomarenko M.S., Volokh 
D.S., Gudzenko A.P., Syatynya M.L., Sosin I.K., 
Trakhtenberg I.M., Voloshin P.V., Gubskiy 
Y.I., Maruta N.O., Linsky I.V., Minko O.I. and 
others, the reserves in the manufacture of the 
extemporal medicines in pharmacies are great, 
and this is due to the fact that there are more 
and more violations of the eligible for aid pa­
tients’ rights, the wholesale and retail prices 
are not set and enforced by budgets of differ­
ent levels [10, 19].
Therefore, developing the concept of the 
extemporal medicines can effectively influ­
ence the pharmacokinetic and pharmacody-
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namic aspects of drug use, including improv­
ing the accuracy of dosing [3, 29]. Due to the 
lack of ready-made medicines and the need­
ed doses of the drug, the patient has to take 
the medicine in smaller doses [17]. Very often 
such cases occur in neurology, psychiatry, on­
cology, addiction therapy, where due to pro­
longed use of drugs in the implementation of 
pharmacotherapy the sick constantly require 
the adjustment of the dose components of the 
extemporal medicines on rational solution to 
the problem of individual dosage of the extem­
poral medicines in patients with mental health 
disorders [25].
Appeals from the citizens to the hotline of 
the Department of Healthcare of Kharkiv Re­
gional State Administration is an example of 
the fact that in healthcare, there is an imperfect 
supervisory system of providing patients with 
mental health disorders with drugs relevant to 
clinical and pharmaceutical, legal and classifi­
cation nomenclature and legal groups, as evi­
denced by the following examples of forensic 
pharmaceutical practice [18, 19, 23, 24].
Example 1. On 09.09.2014, Ms. E. con­
tacted the hotline with complaints about vio­
lations of human rights, complaining that her 
son K., a disabled person of group II, suffering 
from mental illness is not provided with drugs 
Halopryl and Azapin at a discount prescrip­
tion. It was found that one patient received 
only preferential Tsiklodol drug and Azapin 
drug suggested at a dose four times less than 
the prescribed one. He was denied in provid­
ing the drug Halopryl. Based on consultation 
with the doctor, it was suggested to make a 
combined dosage form using substances Hal- 
operidol (general classification legal group), 
Dimedrol (potent legal classification group), 
Azapin (general classification legal group) and 
Tsiklodol (toxic classification Andlegal group) 
in the pharmacy.
Example 2. On 24.01.2014, Ms. T. contact­
ed the hotline with complaints about viola­
tions of human rights complaining of the un­
reasonable refusal to provide her son N., born 
in 1997, a patient with symptomatic epilepsy 
(frequent polymorphic attacks) with reduced 
cost drugs Finlepsyn, Depakin-chrono and Di-
phenine that, according to T., is the violation 
of human rights. As sedative drugs in psychi­
atric disorders, doctors recommend the use 
of compounds which include valerian, orega­
no, hops, cudweed, inula rootstalks and some 
other herbs. One should note that due to the 
selected combination of selected components 
there m ay be a decrease in the daily weight of 
an active pharmaceutical ingredient with in­
creased efficiency due to combined drug po­
tentiation of its components.
Example 3. Investigators of the city of Konotop 
police station of the Ministry of Internal Affairs 
of Ukraine in Sumy Region immediately opened 
criminal proceedings under part 2, art. 307, part 
2, art. 309, art. 311 and art. 313 of the Criminal 
Code of Ukraine. During the preliminary inves­
tigation, it was found that on 17.10.2014, during 
search operations in the apartment, the represen­
tatives of several police departments in the city 
of Konotop have detained four members of an 
organized criminal group, which was equipped 
with a laboratory identified as a “mini-factory” 
of illegal circulation (purchase, storage, produc­
tion) of psychotropic substances. The chief of the 
criminal group, a 39-year-old man previously 
convicted for crimes on the art. 307 of the Crim­
inal Code of Ukraine for four years of imprison­
ment, had formed a criminal group and divided 
responsibilities between the members. Thus, 
in a rented apartment, there was organized an 
underground laboratory for the manufacture of 
psychoactive substances (surfactants) sold at a 
price of 300 USD for 1 gram to the trusted clients 
suffering from mental and neurological disor­
ders. During the search, the police officers found 
and withdrew, according to the findings of the 
forensic examination of pharmaceutical labora­
tory, the equipment for manufacture of surfac­
tants; laboratory glassware (banks, flasks, test 
tubes, refrigerators, etc.); 2 grams of psychoac­
tive substance amphetamine; precursors. There 
were several criminological examinations on the 
case (forensic, pharmaceutical, forensic, forensic 
and narcological). The criminal group chief, ac­
cording to the findings of forensic expertise, was 
registered with a doctor, a psychiatrist, due to a 
long abuse of psychoactive substances including 
the drugs produced by himself, and is in need of
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psychiatric treatment. The organizer of the crim­
inal group was temporarily detained through a 
court proceeding As for the other members of 
the group, there were selected some other pre­
ventive measures. The pre-trial investigation is 
being carried on.
As the example 3 shows, the violated prin­
ciples of the pharmaceutical law in the chain of 
legal relationships “doctor -  patient -  pharma­
cist -  lawyer” lead to the practice when patients 
suffering from mental disorders and having 
no legal access to drugs provided to different 
groups at discount prescriptions or Form 3 pre­
scriptions, are forced to apply to persons en­
gaged in illegal circulation of the psychoactive 
substances (amphetamine) due to the disease 
and pains of various genesis.
The rights of citizens for drug provision (ex­
amples 1, 2, 3), including patients with mental 
disorders who need vital drugs (Haloperidol, 
Azapin, Tsiklodol, Finlepsyn, Depakin-Chro- 
no and Diphenine) are guaranteed through 
the pharmaceutical law and by local budgets 
(formed from the state budget subsidies) under 
the current Decree of the Cabinet of Ministers of 
Ukraine of 17.08.1998 №1303 “On regulation of 
free and concessional dispensing medicines pre­
scribed by doctors in the case of outpatient treat­
ment of certain groups and in certain categories 
of diseases” [18].
The principles of pharmaceutical law are giv­
en in Article 4 of the Law of Ukraine “On Health­
care” and include:
-  Recognition of health care as a priority of 
the state and society, as one of the main factors 
of survival and development of the people of 
Ukraine;
-  Observance of human and citizens’ rights 
and freedoms in the field of health, and securing 
related government guarantees;
-  Humanistic orientation, the priority of hu­
man values over class, national, group or indi­
vidual interests, increased medical and social 
protection of the most vulnerable categories of 
people;
-  Equality of citizens, democracy and acces­
sibility of health care and other services in the 
health sector;
-  Compliance with the objectives and the lev­
el of socio-economic and cultural development 
of society, the scientific validity, logistical and 
financial security;
-  Focus on current standards of health and 
medical care, a combination of local traditions 
and achievements of international experience in 
health care;
-  Preventive nature, complex social, environ­
mental and medical approach to healthcare;
-  Stratification of health economics and multi 
financing of it, the combination of state guaran­
tees monopolization and encouraging entrepre­
neurship and competition;
-  Decentralization of public administration, 
the development of government institutions and 
independence of health workers on the legal and 
contractual basis.
Thus, there is a problem with implemen­
tation of the principles laid down in Articles 3 
and 49 of the Constitution of Ukraine to provide 
a preferential contingent of citizens with drugs 
dispensed at discount prescriptions, namely, 
Haloperidol, Azapin, Tsiklodol, Finlepsyn, De- 
pakin-Chrono and Biphenyl.
To ensure the patients’ access to the legal 
system of the extemporal medicines in the 
“doctor-patient-pharm acist” system there 
must be resolved the following issues shown in 
Fig. 2.
C O N C L U S IO N S . The working group has 
worked out the proposals received from em­
ployees and practical pharmacy patients on 
the improvement of pharmaceutical legislation 
with the aim of approaching individual manu­
facture of extemporal prescriptions based on 
the individual characteristics of the patient. 
Thus, there were processed some problem at­
ic issues regarding patients with mental dis­
orders belonging to a privileged contingent 
with finished pharmaceutical products. It was 
determined that the pharmaceutical law prin­
ciples contribute to solving this problem the 
doctors’ use of extemporal medicines made 
in pharmacies. There were proposed some 
relevant amendments to the normative docu­
ments.
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Fig. 2. The urgent problem areas 
in the system o f  “doctor-patient-pharmacist” relationship 
Рис. 2. Проблемные вопросы в системе правоотношений 
«врач-пациент-провизор»
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